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Background: Cigarette smokers have increased white blood cell (WBC) counts and the activation of tumor
necrosis factor (TNF). The effect of smoking on WBC counts and TNF system activity, however, has not been
separately investigated yet.
Subjects and Methods: One hundred and forty-two Japanese male subjects with normal glucose tolerance were
recruited. They were stratified into two groups based on the questionnaire for smoking: one with current smokers
(n = 48) and the other with current non-smokers (n = 94). Whereas no significant differences were observed in
age, BMI, high molecular weight (HMW) adiponectin, and TNF-a between the two groups, current smokers had
significantly higher soluble TNF receptor 1 (sTNF-R1) (1203 ± 30 vs. 1116 ± 21 pg/ml, p = 0.010) and increased
WBC counts (7165 ± 242 vs. 5590 ± 163/μl, p < 0.001) and lower HDL cholesterol (55 ± 2 vs. 60 ± 1 mg/dl, p =
0.031) as compared to current non-smokers. Next, we classified 48 current smokers into two subpopulations: one
with heavy smoking (Brinkman index ≥ 600) and the other with light smoking (Brinkman index < 600).
Results: Whereas no significant difference was observed in age, BMI, HMW adiponectin, WBC counts and TNF-a,
sTNF-R1 and sTNF-R2 were significantly higher in heavy smoking group (1307 ± 44 vs. 1099 ± 30 pg/ml, p < 0.001;
2166 ± 86 vs. 827 ± 62 pg/ml, p = 0.005) than in light smoking group, whose sTNF-R1 and sTNF-R2 were similar to
non-smokers (sTNF-R1: 1116 ± 15 pg/ml, p = 0.718, sTNF-R2; 1901 ± 32 pg/ml, p = 0.437). In contrast, WBC counts
were significantly increased in heavy (7500 ± 324/μl, p < 0.001) or light (6829 ± 352/μl, p = 0.001) smoking group
as compared to non-smokers (5590 ± 178/μl). There was no significant difference in WBC counts between heavy
and light smoking group (p = 0.158).
Conclusion: We can hypothesize that light smoking is associated with an increase in WBC counts, while heavy
smoking is responsible for TNF activation in Japanese male subjects with normal glucose tolerance.
Background
It is well recognized that smoking is one of the most
important factors contributing to the evolution of ather-
osclerosis and chronic obstructive pulmonary disease in
humans [1,2]. It is well established that current smokers
are characterized by increased white blood cell (WBC)
counts and increased tumor necrosis factor-a(TNF-a)
[3,4]. However, the effects of smoking on the increase in
WBC counts and TNF-a have not been separately inves-
tigated yet. In this regard, a major problem is that com-
pared with circulating TNF-a, soluble TNF receptor
(soluble TNF receptor 1 (sTNF-R1) and soluble TNF
receptor 2 (sTNF-R2)) levels remain elevated for longer
periods of time and are of more value for monitoring
TNF system activities. Another problem is that the
degree of glucose tolerance or of body mass index per
se is considered to affect WBC counts and TNF system
activity in man. To overcome these difficulties, we
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whose BMI is less than 29.0 kg/m
2 a n dm e a s u r e ds o l u -
ble TNF receptors along with TNF-a.
Subjects and Methods
Participants and Setting
A total of 142 Japanese male subjects with normal glu-
cose tolerance who visited Yodogawa Christian Hospital
for the medical checkup were enrolled for the present
study after the ethics committee of Yodogawa Christian
Hospital approved the protocol and informed written
consents were obtained from every participant. Body
mass index in these subjects was 23.2 ± 0.2 kg/m
2
(mean ± SEM). Exclusion criteria were cancer, ischemic
heart disease, cerebral stroke, renal disease, hepatic dis-
ease, asthma, or any inflammatory disease such as rheu-
matoid arthritis or inflammatory bowel disease. Six (4%)
of the 142 subjects were treated with antihypertensive
medications. Twelve (8%) of the 142 subjects were trea-
ted with lipid lowering agents. No subjects have received
any medications known to alter glucose tolerance.
Before the study, they did not use anti-inflammatory
medication. All subjects had ingested at least 150 g of
carbohydrate for the 3 consecutive days preceding the
study. They did not consume alcohol or perform heavy
exercise for at least one week before the study.
Definitions of Active Smoking
Smokers and non-smokers were determined based on
the questionnaire for smoking. Smokers were further
classified into two subgroups based on the value of
Brinkman index; one with heavy smoking (Brinkman
index ≧ 600) and the other with light smoking (Brink-
man index < 600). Brinkman index was calculated as the
product of the number of tobacco smoked and inhaled
year [5]. Miyatake et al. [6] recently demonstrated that
the subjects with a Brinkman index ≧ 600 are at
increased risk for metabolic syndrome as compared to
those with a Brinkman index less than 600 in Japanese
men.
Blood Analysis
Blood was drawn from the antecubital vein in the morn-
ing after a 12-hour fast. Plasma glucose, triglyceride,
total cholesterol, HDL cholesterol, LDL cholesterol,
white blood cell counts, serum creatinine, and hemoglo-
bin A1c were measured. Hemoglobin A1c (HbA1c) was
shown in NGSP values as recommended by the Japan
Diabetes Society [7,8]. Along with TNF-a,s o l u b l eT N F
receptors (sTNF-R1, sTNF-R2) were measured in the
present study. Serum TNF-a concentrations were mea-
s u r e db ye n z y m ei m m u n o a s s a yk i t( Q u a n t i k i n eH S
Human TNF-a immunoassay kit, R&D systems. Inc,
Minneapolis, MN, USA) and serum concentrations of
sTNF-R1 and sTNF-R2 were measured by enzyme-
linked immunosorbent assay (ELISA) (BIOTRAK, Amer-
sham Life Sciences, Uppsala, Sweden), as described pre-
viously [9-12]. The limits of sensitivity for TNF-a,
sTNF-R1 and sTNF-R2 were 0.5 pg/ml, 25 pg/ml and
50 pg/ml, respectively. The intra-assay and interassay
coefficients of variation were less than 8% for TNF-a,
sTNF-R1 and sTNF-R2. Insulin and high molecular
weight adiponectin (HMW adiponectin) were measured
as described previously [11,13]. Samples for TNF, insu-
lin, and HMW adiponectin were prepared, frozen, and
stored at -70°C until the assay. The estimate of insulin
resistance by HOMA (HOMA-IR) was calculated with
the formula: fasting serum insulin (μU/ml) × fasting glu-
cose (mmol/l)/22.5 [14]. We previously demonstrated
that HOMA-IR is strongly correlated with minimal
model derived insulin sensitivity in Japanese subjects
with varying degrees of glucose tolerance [15]. Body fat
percentage was measured using bioelectrical impedence
method.
Statistical Analysis
Data were presented as means ± SEM. Statistical ana-
lyses were conducted using the StatView 5 system (Stat-
view, Berkeley, CA). The differences between smokers
and non-smokers were analyzed by Student’st - t e s t .
When more than two groups were compared, the signif-
icance of differences between any two groups was deter-
mined using Bonferroni’s multiple range test. p <0 . 0 5
was considered significant.
Results
Table 1 shows the clinical profiles in the subjects stu-
died. They were all Japanese males with normal glucose
tolerance. They were divided into two groups based on
the questionnaire for smoking; one with current smo-
kers (n = 48) and the other with current non-smokers
(n = 94). There was no significant difference in age
( 5 1 . 5±1 . 2v s5 2 . 5±1 . 0y r ,p = 0.286), BMI (23.1 ± 0.4
vs 23.2 ± 0.2 kg/m
2, p = 0.389), waist circumference
(84.5 ± 1.0 vs 83.8 ± 0.7 cm, p = 0.286), body fat per-
centage (21.2 ± 0.7 vs 20.6 ± 0.4%, p = 0.217), systolic
(119 ± 2 vs 122 ± 1 mmHg, p = 0.077) and diastolic (75
± 1 vs 75 ± 1 mmHg, p = 0.481) blood pressure, fasting
glucose (95 ± 1 vs 95 ± 1 mmHg, p =0 . 4 7 3 ) ,H b A 1 c
(5.12 ± 0.04 vs 5.15 ± 0.03%, p = 0.250), fasting insulin
(3.8 ± 0.3 vs 3.9 ± 0.2 μU/ml, p =0 . 4 0 8 ) ,H O M A - I R
(0.88 ± 0.08 vs 0.90 ± 0.05, p = 0.403), total cholesterol
(199 ± 5 vs 204 ± 3 mg/dl, p = 0.190), triglyceride (130
±1 1v s1 2 1±4m g / d l ,p = 0.328), and LDL cholesterol
(116 ± 5 vs 117 ± 3 mg/dl, p = 0.437) between the two
groups. Although 2 hour glucose concentration after 75
g oral glucose load was similar between smokers and
non-smokers (115 ± 2 vs 112 ± 2 mg/dl, p = 0.158),
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in non-smokers (55 ± 2 vs 60 ± 1 mg/dl, p = 0.031).
Whereas TNF-a(1.64 ± 0.15 vs 1.47 ± 0.09 pg/ml, p =
0.161) and sTNF-R2(1997 ± 58 vs 1901 ± 45 pg/ml, p =
0.102) were not significantly different between the two
groups, sTNF-R1 (1203 ± 30 vs 1116 ± 22 pg/ml, p =
0.010) and WBC counts (7165 ± 242 vs 5590 ± 168/μl,
p < 0.001) were significantly higher in smokers than in
non-smokers. No significant difference was observed in
HMW adiponectin (5.6 ± 0.6 vs 5.4 ± 0.4 μg/ml, p =
0.358) between the two groups.
Our present study showed that there was a wide varia-
tion in Brinkman index in 48 current smokers (range,
100 to 1840). We therefore classified 48 current smokers
into two groups based on the value of Brinkman index:
one with heavy smoking (Brinkman index ≧ 600) and
the other with light smoking (Brinkman index < 600)
(Table 2).
The subpopulations did not differ with respect to age,
BMI, waist circumference, body fat percentage, systolic
and diastolic blood pressure, fasting glucose, HbA1c,
serum creatinine, lipid profile, HOMA-IR, and HMW
adiponectin. Whereas no significant difference was
observed in WBC counts and TNF-a,s T N F - R 1a n d
sTNF-R2 were significantly higher in heavy smoking
group than in light smoking group, whose sTNF-R1 and
sTNF-R2 were similar to those of non-smokers. In con-
trast, WBC counts were significantly higher in heavy or
light smoking group as compared to non-smokers.
There was, however, no significant difference in WBC
counts between the two smoking groups.
Finally, we compared WBC counts and TNF system
activities taking into account the inhaled year and the
number of tobacco smoked. Inhaled year did not signifi-
cantly affect WBC counts or TNF system activities in
smokers (data not shown). In contrast, the number of
tobacco smoked differently affected WBC and TNF in
smokers (Table 3). Irrespective of the number of
tobacco smoked, WBC counts were significantly higher
in smokers as compared to non-smokers. However, no
significant difference was observed in WBC counts
between smokers who smoked < 20 cigarettes per day
and those who smoked ≧ 20 cigarettes per day. On the
other hand, TNF system activities (sTNF-R1, sTNF-R2)
were not statistically significant between non-smokers
and current smokers who smoked < 20 cigarettes per
day, but they were significantly higher in current smo-
kers who smoked ≧ 20 cigarettes per day as compared
to those who smoked < 20 cigarettes per day or to non-
smokers.
Discussion
In the present study, we confirmed that not only white
blood cell (WBC) counts but also tumor necrosis factor
(TNF) system activities are increased in current smokers
when compared with current non-smokers. However,
smoking affected differently on WBC counts and TNF
system activities. Light smoking was associated with
WBC counts, while heavy smoking was associated with
TNF system activities.
As an index of active smoking, we used Brinckman
index in the current study. Brinkman index is calculated
as the product of the number of tobacco smoked and
the inhaled year. Thus, it is not clear whether which of
the two variables is responsible for the increase in WBC
counts or the activation in TNF system in smokers. We
therefore compared WBC counts and TNF system activ-
ities taking into account the inhaled year and the num-
ber of tobacco smoked. Inhaled year did not
significantly affect WBC counts or TNF system activities
in smokers. In contrast, the number of tobacco smoked
differently affected WBC and TNF system in smokers
(Table 3). Thus, the number of tobacco smoked per se
seems to be independently responsible for the increase
in WBC counts and TNF activation in our current
smokers.
The reason why heavy smoking is associated with
TNF system activity is not known, but it may suggest
that the smoke-induced activation of TNF system
Table 1 Clinical characteristics of the 142 male subjects
studied.
age (yr) 52.1 ± 0.8
body mass index (kg/m
2) 23.2 ± 0.2
waist circumference (cm) 84.0 ± 0.6
body fat percentage (%) 20.8 ± 0.4
systolic blood pressure (mmHg) 121 ± 1
diastolic blood pressure (mmHg) 75 ± 1
fasting glucose (mg/dl) 95 ± 1
2 hr glucose after OGTT (mg/dl) 113 ± 5
HbA1c (%) 5.14 ± 0.02
total cholesterol (mg/dl) 202 ± 3
triglyceride (mg/dl) 124 ± 10
HDL cholesterol (mg/dl) 59 ± 1
LDL cholesterol (mg/dl) 117 ± 3
serum creatinine (mg/dl) 0.80 ± 0.01
insulin (μU/ml) 3.82 ± 0.18
HOMA-IR 0.90 ± 0.18
TNF-a (pg/ml) 1.53 ± 0.08
sTNF-R1 (pg/ml) 1145 ± 180
sTNF-R2 (pg/ml) 1933 ± 356
HMW adiponectin (μg/ml) 5.5 ± 0.3
WBC (/μl) 6123 ± 151
Values represent mean ± SEM.
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This idea is supported from the observation shown by
Zoppini et al. [16] that a marked increase of TNF-a sys-
tem activation was observed with an increase in the
number of cigarettes smoked.
Of particular note in the present study is that these
findings were obtained after taking into account some
variables including BMI, waist circumference, body fat
percentage, blood glucose, HbA1c, and HMW adiponec-
tin which are considered to affect TNF system activities
and/or WBC counts [17,18]. It may be argued that smok-
ing is associated with visceral fat accumulation. It seems,
however, unlikely since Komiya et al. [19] did not fail to
draw a conclusion that smoking is a strong and an inde-
pendent risk factor for inducing excessive accumulation
of visceral fat to a greater extent than sedentary life style
or heavy alcohol consumption in Japanese men.
The mechanisms by which smokers have an increase
in sTNF-R1 are not known at present. The possible
explanation is that smoking exerts an inflammatory sti-
mulus on macrophage which causes the release of TNF-
a. One of the major organs contributing to the produc-
tion of TNF may be the pulmonary alveolar cells.
Another organ might be periodontal tissue. It is
reported that TNF-a content of the gingival crevicular
fluid from smokers is reported to be significantly
increased as compared with non-smokers [20]. Whereas
we did not check the status of periodontal disease in the
subjects studied, we previously demonstrated that
sTNF-R1 serum levels were independently associated
with the severity of periodontal disease in Japanese sub-
jects [21]. In addition, our team previously reported that
the therapy of periodontal disease leads to the reduction
in TNF-a in Japanese subjects [22].
It may be argued that adipose tissue might be another
organ responsible for the increased TNF system activity
in smokers. It seems, however, unlikely, since mean BMI
in our subjects was 23.2 kg/m
2.I nv i t r os t u d ys h o w nb y
Table 2 Clinical characteristics in non-smokers and smokers.
non-smokers smokers
light smoking heavy smoking
number of subjects 94 24 24
Brinkman index 0 385 ± 27
A 914 ± 59
AB
number of tobacco smoked per day 0 15.2 ± 0.9
A 28.3 ± 1.4
AB
inhaled year (yr) 0 25.8 ± 1.4
A 32.6 ± 1.4
AB
age (yr) 52.5 ± 1.0 49.3 ± 1.7 53.8 ± 1.5
body mass index (kg/m
2) 23.2 ± 0.2 22.8 ± 0.6 23.3 ± 0.5
body fat percentage (%) 20.6 ± 0.4 20.8 ± 1.0 21.6 ± 1.0
waist circumference (cm) 83.8 ± 0.7 84.1 ± 1.4 84.9 ± 1.5
systolic blood pressure (mmHg) 122 ± 1 120 ± 3 117 ± 2
diastolic blood pressure (mmHg) 75 ± 1 76 ± 2 74 ± 2
fasting glucose (mg/dl) 95 ± 1 97 ± 1 92 ± 1
2 hr glucose after OGTT (mg/dl) 112 ± 2 115 ± 4 116 ± 3
HbA1c (%) 5.15 ± 0.03 5.10 ± 0.05 5.14 ± 0.06
total cholesterol (mg/dl) 204 ± 3 193 ± 7 205 ± 7
triglyceride (mg/dl) 121 ± 14 138 ± 18 123 ± 13
HDL cholesterol (mg/dl) 60 ± 1 57 ± 3 54 ± 3
LDL cholesterol (mg/dl) 117 ± 3 109 ± 7 124 ± 7
serum creatinine (mg/dl) 0.81 ± 0.01 0.81 ± 0.01 0.79 ± 0.02
insulin (μU/ml) 3.8 ± 0.2 3.5 ± 0.4 4.1 ± 0.6
HOMA-IR 0.90 ± 0.05 0.83 ± 0.09 0.93 ± 0.13
TNF-a (pg/ml) 1.47 ± 0.09 1.82 ± 0.28 1.46 ± 0.11
sTNF-R1 (pg/ml) 1116 ± 21 1099 ± 30 1307 ± 44
AB
sTNF-R2 (pg/ml) 1901 ± 44 1827 ± 62 2166 ± 86
AB
HMW adiponectin (μg/ml) 10.7 ± 0.8 11.4 ± 1.7 11.1 ± 1.5
leptin (ng/ml) 25.6 ± 1.4 23.2 ± 2.0 24.5 ± 2.4
WBC (/μl) 5590 ± 163 6829 ± 352
A 7500 ± 324
A
(light smoking & heavy smoking) Values represent mean ± SEM.
A: p< 0.01 (vs. non-smokers)
B: p< 0.01 (vs. light smoking)
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jects with a BMI greater than 30 kg/m
2 released more
TNF than those with a BMI less than 25 kg/m
2.
Whereas the contributory factors underlying tobacco-
induced atherosclerosis in humans remain to be eluci-
dated, our present study might suggest that sTNF-R1
could become one of the candidates responsible for
tobacco-induced atherosclerosis in humans. Rauchhaus
et al. [24] disclosed that sTNF-R1 is predictive of cardi-
ovascular mortality in patients with chronic heart fail-
ure. Our team demonstrated that sTNF-R1 is associated
with albuminuria or serum homocysteine in Japanese
type 2 diabetic patients [10,25]. Not only albuminuria
but also serum homocysteine are known to be responsi-
ble for the development of atherosclerosis in man.
Pinto-Sietsma et al. reported that smoking is related to
albuminuria in humans [26]. Jatoi et al. [27] showed a
significant linear relationship between smoking status
and pulse wave velocity in man. We previously found
that TNF system activities are independently associated
with pulse wave velocity in non-obese Japanese type 2
diabetic patients [12].
Conclusions
In summary, it can be concluded that smoking is asso-
ciated with increased WBC counts and increased activity
of the TNF system, but the effect of smoking on WBC
counts and TNF system activity was different in Japa-
nese male subjects with normal glucose tolerance. Light
smoking was associated with an increase in WBC
counts, while heavy smoking was responsible for TNF
activation in Japanese male subjects with normal glucose
tolerance.
Abbreviations
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number of subjects 94 24 24
number of cigarettes a day 0 12.3 ± 0.8
A 26.1 ± 1.2
AB
inhaled year (yr) 0 27.8 ± 2.0
A 29.8 ± 1.3
A
Brinkman index 0 348 ± 37
A 786 ± 59
AB
age (yr) 52.5 ± 1.0 52.5 ± 1.9 51.1 ± 1.5
body mass index (kg/m
2) 23.2 ± 0.2 22.2 ± 0.7 23.5 ± 04
waist circumference (cm) 83.8 ± 0.7 82.6 ± 1.7 85.3 ± 1.3
body fat percentage (%) 20.6 ± 0.4 19.7 ± 1.4 21.9 ± 0.7
systolic blood pressure
(mmHg)
122 ± 1 120 ± 3 118 ± 2
diastolic blood pressure
(mmHg)
75 ± 1 75 ± 2 75 ± 2
fasting glucose (mg/dl) 95 ± 1 95 ± 2 94 ± 1
2 hr glucose after OGTT
(mg/dl)
112 ± 2 114 ± 5 116 ± 3
HbA1c (%) 5.15 ± 0.03 5.09 ± 0.07 5.14 ± 0.04
total cholesterol (mg/dl) 204 ± 3 198 ± 8 200 ± 6
triglyceride (mg/dl) 121 ± 14 140 ± 20 126 ± 13
HDL cholesterol (mg/dl) 60 ± 1 55 ± 4 56 ± 3
LDL cholesterol (mg/dl) 117 ± 3 116 ± 7 117 ± 7
serum creatinine (mg/dl) 0.81 ± 0.01 0.78 ± 0.04 0.78 ± 0.02
insulin (μU/ml) 3.9 ± 0.2 3.2 ± 0.5 4.0 ± 0.4
HOMA-IR 0.90 ± 0.05 0.77 ± 0.13 0.93 ± 0.10
TNF-a (pg/ml) 1.47 ± 0.09 2.00 ± 0.45 1.47 ± 0.09
sTNF-R1 (pg/ml) 1116 ± 22 1072 ± 37 1263 ± 36
AB
sTNF-R2 (pg/ml) 1901 ± 45 1767 ± 80 2101 ± 70
ab
HMW adiponectin (μg/ml) 10.7 ± 0.8 12.8 ± 2.2 10.5 ± 1.3
leptin (ng/ml) 25.6 ± 1.4 20.9 ± 2.3 25.2 ± 2.0
WBC(/μl) 5590 ± 168 6687 ± 396
a 7382 ± 298
A
(light smoking & heavy smoking) Values represent mean ± SEM.
A: p < 0.01 (vs. non-smokers)
B: p < 0.01 (vs. light smoking)
a: p < 0.05 (vs. non-smokers)
b: p < 0.05 (vs. light smoking)
Watanabe et al. Tobacco Induced Diseases 2011, 9:12
http://www.tobaccoinduceddiseases.com/content/9/1/12
Page 5 of 6Competing interests
The authors declare that they have no competing interests.
Received: 2 May 2011 Accepted: 25 November 2011
Published: 25 November 2011
References
1. Laniado-Laborin R: Smoking and choronic obstructive pulmonary disease
(COPD). Parallel Epidemics of the 21
st Century. Int J Environ Res Public
Health 2009, 6:209-224.
2. Howard G, Wagenknecht LE, Burke GL, et al: Cigarette smoking and
progression of atherosclerosis: The Athrosclerosis Risk in Communities
(ARIC) Study. JAMA 1998, 279:119-124.
3. Taylor RG, Woodman G, Clarke SW: Plasma nicotine concentration and
white blood cell counts in smokers. Thorax 1986, 41:407-408.
4. Petrescu F, Voican SC, Silosi I: Tumor necrosis factor-α serum levels in
healthy smokers and nonsmokers. Int J Chronic Obstructive Pulmonary
Disease 2010, 5:217-222.
5. Brinkman GL, Coates EO Jr: The effect of bronchitis, smoking and
occupation on ventilation. Ann Respir Dis 1963, 87:684-693.
6. Miyatake N, Wada J, Kawasaki Y, et al: Relationship between metabolic
syndrome and cigarette smoking in the Japanese population. Int Med
2006, 1039-1043.
7. Seino Y, Nanjo K, Tajima N, et al: Report of the Committee on the
Classification and Diagnostic Criteria of Diabetes Mellitus. Journal of
Diabetes Investigation 2010, 1:212-228.
8. Seino Y, Nanjo K, Tajima N, et al: Report of the Committee on the
Classification and Diagnostic Criteria of Diabetes Mellitus. Diabetology
International 2010, 1:2-20.
9. Yatagi T, Nagasaka S, Taniguchi A, et al: Hypoadiponecinemia is associated
with visceral fat accumulation and insulin resistance in Japanese men
with type 2 diabetes mellitus. Metabolism 2003, 52:1274-1278.
10. Kawasaki Y, Taniguchi A, Fukushima M, et al: Soluble TNF receptors and
albuminuria in non-obese Japanese type 2 diabetic patients. Horm
Metab Res 2004, 37:617-621.
11. Ohya M, Taniguchi A, Fukushima M, et al: Three measures of tumor
necrosis factor α activity and insulin resistance in nonobese Japanese
type 2 diabetic patients. Metabolism 2005, 54:1297-1301.
12. Ohgushi M, Taniguchi A, Fukushima M, et al: Soluble tumor necrosis factor
receptor 2 is independently associated with pulse wave velocity in
nonobese Japanese patients with type 2 diabetes mellitus. Metabolism
2007, 56:571-577.
13. Taniguchi A, Fukushima M, Kuroe A, et al: Metabolic syndrome, insulin
resistance, and atherosclerosis in Japanese type 2 diabetic patients.
Metabolism 2007, 56:1099-1103.
14. Matthews D, Hosker J, Rudenski A, et al: Homeostasis model assessment:
Insulin resistance and B-cell function from fasting plasma glucose and
insulin concentrations in man. Diabetologia 1985, 28:412-419.
15. Fukushima M, Taniguchi A, Sakai M, et al: Homeostasis model assessment
as a clinical index of insulin resistance (letter). Diabetes Care 1999,
22:1911-1912.
16. Zoppini G, Faccini G, Muggeo M, et al: Elevated plasma levels of soluble
receptors of TNF-α and their association with smoking and
microvascular complications in young adults with type 1 diabetes. J Clin
Endocrinol Metab 2001, 186:3805-3808.
17. Tsatsanis C, Zacharioudaki V, Androulidaki A, et al: Adiponectin induces
TNF-alpha and IL-6 in macrophages and promotes tolerance to itself
and other pro-inflammatory stimuli. Biochem Bophys Res Commun 2005,
335:1254-1263.
18. Hector J, Schwarzloh B, Goehring J, et al: TNF-alpha alters visfatin and
adiponectin levels in human fat. Horm Metab Res 2007, 39:250-255.
19. Komiya H, Mori Y, Yokose T, et al: Smoking as a risk factor for visceral fat
accumulation in Japanese men. Tohoku J Exp Med 2006, 208:123-132.
20. Bostrom L, Linder LE, Bergstrom J: Smoking and cervicular fluid levels of
IL-6 and TNF-α in periodontal disease. J Clin Periodontal 1999, 26:352-357.
21. Nomura Y, Taniguchi A, Fukushima M, et al: Soluble TNF receptor and
periodontal disease in non-obese Japanese type 2 diabetic patients
(letter). Horm Metab Res 2006, 38:688-689.
22. Iwamoto Y, Nishimura F, Soga Y, et al: Antimicrobial periodontal
treatment decreases C-reactive protein, tumor necrosis factor-alpha, but
not adiponectin levels in patients with chronic periodontitis. J
Periodontol 2001, 72:774-778.
23. Kern PA, Ranganathan S, Li C, et al: Adipose tissue tumor necrosis factor
and interleukin-6 expression in humans obesity and insulin resistance.
Am J Physiol Endocrinol Metab 2001, 280:E745-E751.
24. Rauchhaus M, Doehner W, Francis DP, et al: Plasma cytokine parameters
and mortality in patients with chronic heart failure. Circulation 2000,
102:3060-3067.
25. Taniguchi A, Fukushima M, Nakai Y, et al: Soluble tumor necrosis factor
receptor 1 is strongly and independently associated with serum
homocysteine in nonobese Japanese type 2 diabetic patients (letter).
Diabetes Care 2006, 29:949-950.
26. Pinto-Sietsma S, Mulder J, Janssen WMT, et al: Smoking is related to
albuminuria and abnormal renal function in nondiabetic persons. Ann
Intern Med 2000, 133:585-591.
27. Jatoi NA, Jerrard-Dunne P, Feely J, et al: Impact of smoking and smoking
cession on arterial stiffness and aortic wave reflection in hypertension.
Hypertension 2007, 49:981-985.
doi:10.1186/1617-9625-9-12
Cite this article as: Watanabe et al.: Smoking, white blood cell counts,
and TNF system activity in Japanese male subjects with normal glucose
tolerance. Tobacco Induced Diseases 2011 9:12.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Watanabe et al. Tobacco Induced Diseases 2011, 9:12
http://www.tobaccoinduceddiseases.com/content/9/1/12
Page 6 of 6